KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Accounts Payables (2016 - 2025)

Evolent Health has reported Accounts Payables over the past 11 years, most recently at $59.8 million for Q4 2025.

  • Quarterly results put Accounts Payables at $59.8 million for Q4 2025, down 37.75% from a year ago — trailing twelve months through Dec 2025 was $59.8 million (down 37.75% YoY), and the annual figure for FY2025 was $59.8 million, down 37.75%.
  • Accounts Payables for Q4 2025 was $59.8 million at Evolent Health, down from $72.2 million in the prior quarter.
  • Over the last five years, Accounts Payables for EVH hit a ceiling of $96.6 million in Q2 2022 and a floor of $37.8 million in Q3 2021.
  • Median Accounts Payables over the past 5 years was $60.8 million (2022), compared with a mean of $64.1 million.
  • Biggest five-year swings in Accounts Payables: surged 200.5% in 2021 and later plummeted 49.28% in 2024.
  • Evolent Health's Accounts Payables stood at $96.1 million in 2021, then plummeted by 40.5% to $57.2 million in 2022, then fell by 15.62% to $48.2 million in 2023, then surged by 99.03% to $96.0 million in 2024, then crashed by 37.75% to $59.8 million in 2025.
  • The last three reported values for Accounts Payables were $59.8 million (Q4 2025), $72.2 million (Q3 2025), and $69.5 million (Q2 2025) per Business Quant data.